Collectively, findings obtained in our study highlighted that Rbpjl decreases Arid5a expression by binding to the Arid5a promoter region, and blocks activation of the IL-6/STAT3 signaling pathway, thus suppressing the expression of inflammatory factors TNF-α, IL-1β and IL-6 in AP. The gene discussed is RBPJL; the disease is alkaline phosphatase measurement.